Bill Text: TX HB597 | 2011-2012 | 82nd Legislature | Introduced
NOTE: There are more recent revisions of this legislation. Read Latest Draft
Bill Title: Relating to designating certain synthetic cannabinoids as controlled substances under the Texas Controlled Substances Act; providing penalties and establishing certain criminal consequences or procedures.
Spectrum: Moderate Partisan Bill (Republican 10-2)
Status: (Introduced - Dead) 2011-05-12 - Laid on the table subject to call [HB597 Detail]
Download: Texas-2011-HB597-Introduced.html
Bill Title: Relating to designating certain synthetic cannabinoids as controlled substances under the Texas Controlled Substances Act; providing penalties and establishing certain criminal consequences or procedures.
Spectrum: Moderate Partisan Bill (Republican 10-2)
Status: (Introduced - Dead) 2011-05-12 - Laid on the table subject to call [HB597 Detail]
Download: Texas-2011-HB597-Introduced.html
82R562 JSC-D | ||
By: Madden | H.B. No. 597 |
|
||
|
||
relating to adding certain synthetic cannabinoids to Penalty Group | ||
2 of the Texas Controlled Substances Act. | ||
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | ||
SECTION 1. Section 481.103(a), Health and Safety Code, is | ||
amended to read as follows: | ||
(a) Penalty Group 2 consists of: | ||
(1) any quantity of the following hallucinogenic | ||
substances, their salts, isomers, and salts of isomers, unless | ||
specifically excepted, if the existence of these salts, isomers, | ||
and salts of isomers is possible within the specific chemical | ||
designation: | ||
alpha-ethyltryptamine; | ||
alpha-methyltryptamine; | ||
4-bromo-2, 5-dimethoxyamphetamine (some trade or | ||
other names: 4-bromo-2, 5-dimethoxy-alpha-methylphenethylamine; | ||
4-bromo-2, 5-DMA); | ||
4-bromo-2, 5-dimethoxyphenethylamine; | ||
Bufotenine (some trade and other names: 3-(beta- | ||
Dimethylaminoethyl)-5-hydroxyindole; 3-(2-dimethylaminoethyl)- 5- | ||
indolol; N, N-dimethylserotonin; 5-hydroxy-N, N- | ||
dimethyltryptamine; mappine); | ||
Diethyltryptamine (some trade and other | ||
names: N, N-Diethyltryptamine, DET); | ||
2, 5-dimethoxyamphetamine (some trade or other | ||
names: 2, 5-dimethoxy-alpha-methylphenethylamine; 2, 5-DMA); | ||
2, 5-dimethoxy-4-ethylamphetamine (trade or other | ||
name: DOET); | ||
2, 5-dimethoxy-4-(n)-propylthiophenethylamine | ||
(trade or other name: 2C-T-7); | ||
Dimethyltryptamine (trade or other name: DMT); | ||
Dronabinol (synthetic) in sesame oil and | ||
encapsulated in a soft gelatin capsule in a U.S. Food and Drug | ||
Administration approved drug product (some trade or other names for | ||
Dronabinol: (a6aR-trans)-6a,7,8,10a-tetrahydro- 6,6, 9- | ||
trimethyl-3-pentyl-6H- dibenzo [b,d]pyran-1-ol or (-)-delta-9- | ||
(trans)- tetrahydrocannabinol); | ||
Ethylamine Analog of Phencyclidine (some trade or | ||
other names: N-ethyl-1-phenylcyclohexylamine, (1- | ||
phenylcyclohexyl) ethylamine, N-(1-phenylcyclohexyl) ethylamine, | ||
cyclohexamine, PCE); | ||
Ibogaine (some trade or other names: 7-Ethyl-6, | ||
6, beta 7, 8, 9, 10, 12, 13-octahydro-2-methoxy-6, 9-methano-5H- | ||
pyrido [1', 2':1, 2] azepino [5, 4-b] indole; tabernanthe iboga.); | ||
Mescaline; | ||
5-methoxy-N, N-diisopropyltryptamine; | ||
5-methoxy-3, 4-methylenedioxy amphetamine; | ||
4-methoxyamphetamine (some trade or other | ||
names: 4-methoxy-alpha-methylphenethylamine; | ||
paramethoxyamphetamine; PMA); | ||
1-methyl- 4-phenyl-4-propionoxypiperidine (MPPP, | ||
PPMP); | ||
4-methyl-2, 5-dimethoxyamphetamine (some trade | ||
and other names: 4-methyl-2, 5-dimethoxy-alpha- | ||
methylphenethylamine; "DOM"; "STP"); | ||
3,4-methylenedioxy methamphetamine (MDMA, MDM); | ||
3,4-methylenedioxy amphetamine; | ||
3,4-methylenedioxy N-ethylamphetamine (Also | ||
known as N-ethyl MDA); | ||
Nabilone (Another name for nabilone: (+)-trans- | ||
3-(1,1-dimethylheptyl)- 6,6a, 7,8,10,10a-hexahydro-1-hydroxy- 6, | ||
6-dimethyl-9H-dibenzo[b,d] pyran-9-one; | ||
N-benzylpiperazine (some trade or other | ||
names: BZP; 1-benzylpiperazine); | ||
N-ethyl-3-piperidyl benzilate; | ||
N-hydroxy-3,4-methylenedioxyamphetamine (Also | ||
known as N-hydroxy MDA); | ||
4-methylaminorex; | ||
N-methyl-3-piperidyl benzilate; | ||
Parahexyl (some trade or other names: 3-Hexyl-1- | ||
hydroxy-7, 8, 9, 10-tetrahydro-6, 6, 9-trimethyl-6H-dibenzo [b, d] | ||
pyran; Synhexyl); | ||
1-Phenylcyclohexylamine; | ||
1-Piperidinocyclohexanecarbonitrile (PCC); | ||
Psilocin; | ||
Psilocybin; | ||
Pyrrolidine Analog of Phencyclidine (some trade | ||
or other names: 1-(1-phenylcyclohexyl)-pyrrolidine, PCPy, PHP); | ||
Tetrahydrocannabinols, other than marihuana, and | ||
synthetic equivalents of the substances contained in the plant, or | ||
in the resinous extractives of Cannabis, or synthetic substances, | ||
derivatives, and their isomers with similar chemical structure and | ||
pharmacological activity such as: | ||
delta-1 cis or trans tetrahydrocannabinol, | ||
and their optical isomers; | ||
delta-6 cis or trans tetrahydrocannabinol, | ||
and their optical isomers; | ||
delta-3, 4 cis or trans | ||
tetrahydrocannabinol, and its optical isomers; | ||
compounds of these structures, regardless of | ||
numerical designation of atomic positions, since nomenclature of | ||
these substances is not internationally standardized; | ||
Thiophene Analog of Phencyclidine (some trade or | ||
other names: 1-[1-(2-thienyl) cyclohexyl] piperidine; 2-Thienyl | ||
Analog of Phencyclidine; TPCP, TCP); | ||
1-pyrrolidine (some trade or other name: TCPy); | ||
1-(3-trifluoromethylphenyl)piperazine (trade or | ||
other name: TFMPP); and | ||
3,4,5-trimethoxy amphetamine; | ||
(2) Phenylacetone (some trade or other | ||
names: Phenyl-2-propanone; P2P, Benzymethyl ketone, methyl benzyl | ||
ketone); [ |
||
(3) unless specifically excepted or unless listed in | ||
another Penalty Group, a material, compound, mixture, or | ||
preparation that contains any quantity of the following substances | ||
having a potential for abuse associated with a depressant or | ||
stimulant effect on the central nervous system: | ||
Aminorex (some trade or other | ||
names: aminoxaphen; 2-amino-5-phenyl-2-oxazoline; 4,5-dihydro-5- | ||
phenyl-2-oxazolamine); | ||
Amphetamine, its salts, optical isomers, and | ||
salts of optical isomers; | ||
Cathinone (some trade or other names: 2-amino-1- | ||
phenyl-1-propanone, alpha-aminopropiophenone, 2- | ||
aminopropiophenone); | ||
Etorphine Hydrochloride; | ||
Fenethylline and its salts; | ||
Lisdexamfetamine, including its salts, isomers, | ||
and salts of isomers; | ||
Mecloqualone and its salts; | ||
Methaqualone and its salts; | ||
Methcathinone (some trade or other names: 2- | ||
methylamino-propiophenone; alpha-(methylamino)propriophenone; | ||
2-(methylamino)-1-phenylpropan-1-one; alpha-N- | ||
methylaminopropriophenone; monomethylpropion; ephedrone, N- | ||
methylcathinone; methylcathinone; AL-464; AL-422; AL-463; and UR | ||
1431); | ||
N-Ethylamphetamine, its salts, optical isomers, | ||
and salts of optical isomers; and | ||
N,N-dimethylamphetamine (some trade or other | ||
names: N,N,alpha-trimethylbenzeneethaneamine; | ||
N,N,alpha-trimethylphenethylamine), its salts, optical isomers, | ||
and salts of optical isomers; and | ||
(4) any quantity of a synthetic chemical compound that | ||
is a cannabinoid receptor agonist and mimics the pharmacological | ||
effect of naturally occurring cannabinoids, including: | ||
naphthoylindoles structurally derived from | ||
3-(1-naphthoyl)indole by substitution at the nitrogen atom of the | ||
indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, | ||
or 2-(4-morpholinyl)ethyl, whether or not further substituted in | ||
the indole ring to any extent, whether or not substituted in the | ||
napthyl ring to any extent, including: | ||
JWH-004; | ||
JWH-007; | ||
JWH-009; | ||
JWH-015; | ||
JWH-016; | ||
JWH-018; | ||
JWH-019; | ||
JWH-020; | ||
JWH-046; | ||
JWH-047; | ||
JWH-048; | ||
JWH-049; | ||
JWH-050; | ||
JWH-070; | ||
JWH-071; | ||
JWH-072; | ||
JWH-073; | ||
JWH-076; | ||
JWH-079; | ||
JWH-080; | ||
JWH-081; | ||
JWH-082; | ||
JWH-094; | ||
JWH-096; | ||
JWH-098; | ||
JWH-116; | ||
JWH-120; | ||
JWH-122; | ||
JWH-148; | ||
JWH-149; | ||
JWH-180; | ||
JWH-181; | ||
JWH-182; | ||
JWH-189; | ||
JWH-193; | ||
JWH-198; | ||
JWH-200; | ||
JWH-210; | ||
JWH-211; | ||
JWH-212; | ||
JWH-213; | ||
JWH-234; | ||
JWH-235; | ||
JWH-236; | ||
JWH-239; | ||
JWH-240; | ||
JWH-241; | ||
JWH-242; | ||
JWH-262; | ||
JWH-386; | ||
JWH-387; | ||
JWH-394; | ||
JWH-395; | ||
JWH-397; | ||
JWH-398; | ||
JWH-399; | ||
JWH-400; | ||
JWH-412; | ||
JWH-413; | ||
JWH-414; and | ||
JWH-415; | ||
naphthylmethylindones structurally derived from | ||
1H-indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen | ||
atom of the indole ring by alkyl, alkenyl, cycloalkylmethyl, | ||
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further | ||
substituted in the indole ring to any extent, whether or not | ||
substituted in the naphthyl ring to any extent, including: | ||
JWH-175; | ||
JWH-184; | ||
JWH-185; | ||
JWH-192; | ||
JWH-194; | ||
JWH-195; | ||
JWH-196; | ||
JWH-197; and | ||
JWH-199; | ||
naphthoylpyrroles structurally derived from | ||
3-(1-naphthoyl)pyrrole by substitution at the nitrogen atom of the | ||
pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, | ||
or 2-(4-morpholinyl)ethyl, whether or not further substituted in | ||
the pyrrole ring to any extent, whether or not substituted in the | ||
naphthyl ring to any extent, including: | ||
JWH-030; | ||
JWH-145; | ||
JWH-146; | ||
JWH-147; | ||
JWH-150; | ||
JWH-156; | ||
JWH-243; | ||
JWH-244; | ||
JWH-245; | ||
JWH-246; | ||
JWH-292; | ||
JWH-293; | ||
JWH-307; | ||
JWH-308; | ||
JWH-346; | ||
JWH-348; | ||
JWH-363; | ||
JWH-364; | ||
JWH-365; | ||
JWH-367; | ||
JWH-368; | ||
JWH-369; | ||
JWH-370; | ||
JWH-371; | ||
JWH-373; and | ||
JWH-392; | ||
naphthylmethylindenes structurally derived from | ||
1-(1-naphthylmethyl)indene by substitution at the 3-position of | ||
the indene ring by alkyl, alkenyl, cycloalkylmethyl, | ||
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further | ||
substituted in the indene ring to any extent, whether or not | ||
substituted in the naphthyl ring to any extent, including JWH-176; | ||
phenylacetylindoles structurally derived from | ||
3-phenylacetylindole by substitution at the nitrogen atom of the | ||
indole ring with alkyl, alkenyl, cycloalkylmethyl, | ||
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not further | ||
substituted in the indole ring to any extent, whether or not | ||
substituted in the phenyl ring to any extent, including: | ||
JWH-167; | ||
JWH-201; | ||
JWH-202; | ||
JWH-203; | ||
JWH-204; | ||
JWH-205; | ||
JWH-206; | ||
JWH-207; | ||
JWH-208; | ||
JWH-209; | ||
JWH-237; | ||
JWH-248; | ||
JWH-249; | ||
JWH-250; | ||
JWH-251; | ||
JWH-252; | ||
JWH-253; | ||
JWH-302; | ||
JWH-303; | ||
JWH-304; | ||
JWH-305; | ||
JWH-306; | ||
JWH-311; | ||
JWH-312; | ||
JWH-313; | ||
JWH-314; | ||
JWH-315; and | ||
JWH-316; | ||
cyclohexylphenols structurally derived from | ||
2-(3-hydroxycyclohexyl)phenol by substitution at the 5-position of | ||
the phenolic ring by alkyl, alkenyl, cycloalkylmethyl, | ||
cycloalkylethyl, or 2-(4-morpholinyl)ethyl, whether or not | ||
substituted in the cyclohexyl ring to any extent, including: | ||
CP-55,940; | ||
CP-47,497; and | ||
analogues of CP-47,497, including VII, V, | ||
VIII, I, II, III, IV, IX, X, XI, XII, XIII, XV, and XVI; and | ||
cannabinol derivatives, except where contained in | ||
cannabis or cannabis resin, including tetrahydro derivatives of | ||
cannabinol and 3-alkyl homologues of cannabinol or of its | ||
tetrahydro derivatives, such as: | ||
delta-9-THC; | ||
delta-8-THC; | ||
Nabilone; | ||
HU-210; | ||
HU-211; and | ||
WIN-55,212-2. | ||
SECTION 2. This Act takes effect September 1, 2011. |